UK Strategy for Industrial Biotechnology Introducing the Industrial Biotechnology Leadership Forum Rebecca Wood Chemistry Innovation KTN 12 th December 2013
UK Strategy for IB : Government Support www.berr.gov.uk/files/file51144.pdf
What is industrial biotechnology? IB is defined as “ the use of biological substances* for the processing and production of enzymes, chemicals, materials and energy”. * plants, algae, marine life, fungi, micro-organisms White Biotechnology Green Biotechnology Blue Biotechnology Use of micro-organisms, Discovery & use of Discovery & use of novel biochemistry, novel genes, processes genes, processes and biocatalysts, and materials in land materials in freshwater engineering and plants, agricultural and marine organisms fermentation crops and forestry Areas of focus: IB for the design and processing of bio-derived raw materials IB for onward processing and manufacture of products
IB 2025 : ‘ Maximising UK Opportunities from Industrial Biotechnology in a Low Carbon Economy’ Sales for UK chemistry-using industry using Industrial Biotechnology •Connecting it all together Driving •De-risking access to new products and technologies •Accelerating the innovation and knowledge transfer process Delivering •Retaining and developing interdisciplinary talent in science The estimated global market and management for IB by 2025: •Creating a supportive public and business environment for Enabling £150 bn - £360 bn industrial biotechnology
Industrial Biotechnology Leadership Forum – The Members •Connecting it all together Driving
Driving a bio-based economy in the UK Events Case studies www.iblf-uk.com Social media
National Industrial Biotechnology Facility (NIBF) •De-risking access to new products and Development Laboratories technologies •Accelerating the innovation and knowledge • Up to 10 litre working volume Delivering transfer process • DSP matched to plant scale up units • Algal processing NIBF 1 • Pilot plant to 750 L • Plug and play processing NIBF 2 • Centre piece is a 10,000 L fermenter • Solvent suite, distillation, wet and dry biomass processing • Focused on biomass to renewable chemicals Multi-disciplinary team Images courtesy of CPI
Academic Centres of Excellence Centre of Excellence for Biocatalysis, The Biorenewables Development Centre Biotransformations and Biocatalytic Manufacturing (CoBio3) Images courtesy of the BDC The BEACON Biorefining Centre of Excellence Images courtesy of the MIB (Manchester Institute of Images courtesy of the BEACON project, Biotechnology) Wales
Company Engagement Programme – The Beginning •De-risking access to new products and technologies •Accelerating the innovation and knowledge Delivering transfer process Follow up / result of company visit New IB project initiated Introduction made Technical input provided 1 Follow up visit 1 1 1 1 2 1 1 4 Basic follow up interest Sector Class 2 2 1 1 1 Primary visit only Bulk Chemicals Specialty Total companies Chemicals engaged per awareness 1 1 2 3 6 7 Environment level Providers Number of Unaware or Aware of Open to Engaged at Engaged at IB is core FMCG 1 companies per resistant IB application R&D commercial business Pharmaceuticals = sector class Company awareness / activity at the time of visit
Company Engagement Programme – January 2013 New products, >300 biocatalytic processes, >400 fermentation processes, >1000 processes, services products based on renewable raw materials: Value est. Up to£5 bn (value generated) 1 2 2 Follow up / result of company visit 1 3 2 1 4 New IB project initiated 1 1 3 1 1 1 3 1 3 2 1 1 1 1 Introduction made 2 1 1 1 3 1 1 1 1 4 Technical input 1 1 1 provided 1 1 1 1 1 1 1 2 1 Follow up visit 1 2 2 1 1 2 5 2 1 5 Basic follow up interest 3 6 1 4 2 3 1 2 Sector Class 2 Primary visit only Bulk Chemicals Specialty Total companies Chemicals 4 14 14 31 31 23 23 29 29 11 11 engaged per awareness Environment level Providers Unaware or Aware of Open to Engaged at Engaged at IB is core Number of FMCG 1 companies per resistant IB application R&D commercial business Pharmaceuticals = sector class Company awareness / activity at the time of visit
Project Building and Funding
Public Investments in Industrial Biotechnology 2009-2012 £12M to establish demonstration facilities – ~£3M pa continued through Catapult funding Up to £3M pa into Feasibility / CR&D Competitions from TSB – TSB Competitions in UK (incl. partnership with Innovation Norway) – European ERANets £2.5M into the Biorenewables Development Centre in York £1M into company engagement programme ~£45M pa from Research Councils into IB in Universities
2013-Onwards RCs and TSB working together: Networks and the IB Catalyst £18M to fund £45M IB 13 Networks Catalyst Fund
Enabling a bio-based economy in the UK •Retaining and developing interdisciplinary talent in science and management •Creating a supportive public and business environment for Enabling industrial biotechnology
Demonstrating progress 2009-2012 and plans 2013-2016 Leading IB: A UK Showcase 300 Delegates • Industry • Academia • IB stakeholders • Funders Ministerial Announcement “Investment for IB Catalyst Fund”
IB Manufacturing Exhibition 5-16 th August 2013
Hurdles still ahead • UK Roadmapping Workshop • Multidisciplinary teams – communication barriers • Competition for feedstock • Impact of shale gas • Incentives for non-fuel bio-based products • Skills • Consumer demand for ‘natural’ at = cost Opportunity to input to European Roadmap – Contact Lynsdey.starr@pnoconsultants.com
Summary • We are on track to deliver the step change in IB for the UK • Multiple delivery partners driving progress towards 4 objectives by 2025 with interim milestones • Looking for even stronger engagement with industry • Working closely with the government on IB • It’s an exciting time to be involved!
Thank you Industrial Biotechnology Leadership Forum • Together we aim to drive uptake of Industrial Biotechnology through-out the chemistry-using industries
Recommend
More recommend
